PPAPDC1B Blocking Peptide (Center)
€363.00
In stock
SKU
AC-BP22010c
Background:
Displays magnesium-independent phosphatidate phosphatase activity in vitro. Catalyzes the conversion of phosphatidic acid to diacylglycerol. May be a metastatic suppressor for hepatocellular carcinoma.
Other Names:
Phosphatidate phosphatase PPAPDC1B, 3.1.3.4, Phosphatidic acid phosphatase type 2 domain-containing protein 1B, PPAPDC1B, DPPL1, HTPAP
Target/Specificity:
The synthetic peptide sequence is selected from aa 134-146 of HUMAN PPAPDC1B
Gene Name: PLPP5 (HGNC:25026)
Gene ID: 84513
Primary Accession: Q8NEB5
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Displays magnesium-independent phosphatidate phosphatase activity in vitro. Catalyzes the conversion of phosphatidic acid to diacylglycerol. May be a metastatic suppressor for hepatocellular carcinoma.
Other Names:
Phosphatidate phosphatase PPAPDC1B, 3.1.3.4, Phosphatidic acid phosphatase type 2 domain-containing protein 1B, PPAPDC1B, DPPL1, HTPAP
Target/Specificity:
The synthetic peptide sequence is selected from aa 134-146 of HUMAN PPAPDC1B
Gene Name: PLPP5 (HGNC:25026)
Gene ID: 84513
Primary Accession: Q8NEB5
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review